/The%20front%20of%20a%20Rocket%20Lab%20corporate%20office%20by%20Emagnetic%20via%20Shutterstock.jpg)
/Caterpillar%20Inc_%20equipment-by%20pabradyphoto%20via%20iStock.jpg)
While Caterpillar has outperformed the broader market over the past year, Wall Street analysts are cautiously optimistic about the stock’s prospects.
/The%20CoreWeave%20logo%20displayed%20on%20a%20smartphone%20screen_%20Image%20by%20Robert%20Way%20via%20Shutterstock_.jpg)
The company more than doubled revenues and narrowed losses in the quarter.
Worried about buying momentum stocks at the top? Married puts pair share ownership with downside protection. Three of yesterday’s stocks with unusually active put options make suitable bets for long-time...
/Quantum%20Computing/A%20concept%20image%20of%20a%20green%20and%20yellow%20motherboard_%20Image%20by%20Gorodenkoff%20via%20Shutterstock_.jpg)
Quantinuum is putting its Helios quantum computer inside Oracle Cloud, pairing quantum power with AI as revenue and bookings surge in Q2.
/Oracle%20Corp_%20office%20logo-by%20Mesut%20Dogan%20via%20iStock.jpg)
Oracle is planning fresh layoffs before September as debt and AI infrastructure spending squeeze cash flow, according to a new report.
Despite Sherwin-Williams' underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
Ondas stock sinks on widened Q2 EBITDA loss. But options pricing suggests the pullback may be a buying opportunity.
Mark Cuban has simple advice for Powerball winners: skip the lump sum, don’t rush into investing, set boundaries with family and friends, and hire a tax attorney first.
As Clorox has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.
Relay Therapeutics (RLAY) is a clinical-stage precision medicines company focused on targeted oncology, with a $4.4 billion market cap. RLAY has surged 486% over the past year. Shares are trading near...
